Hospira (HSP - option chain) stock is trading lower today after the company announced this morning it has agreed to buy Javelin Pharmaceuticals (JAV) for $2.20 per share in cash, or $145 million. HSP expects to begin a tender offer for all shares of JAV on April 21. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on HSP.This morning, HSP opened at $56.15. So far today the stock has hit a high of $56.85 and a low of $54.19. As of 11:50, HSP is trading at $55.30, down $1.80 (-3.1%). The chart for HSP looks neutral and S&P gives HSP a neutral 3 STARS (out of 5) hold ranking.
Savings Experiment: Snow Removal
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


